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1. Introduction 
The purpose of this thesis is to provide an overview of Generalized Estimating Equations 
(GEE) and apply this method of estimation to a cluster-randomized study called IndiMed. 
This master’s thesis consists of three parts: overview of Generalized Estimating 
Equations, a general guideline of how to use GEE in SAS and thirdly a practical part 
where GEE-type models are applied to data from the Estonian Genome Center of 
University of Tartu.  
Theoretical part provides an overview of the Quasi-likelihood estimator and marginal 
models which are the basis of GEE. Different correlation structures, estimation of 
parameters and of their variance is presented. Model inference, interpretation and model 
selection criteria is also discussed.  
In the next section, instructions of using the GEE approach in statistical software SAS are 
presented for two frequently used procedures: PROC GENMOD and PROC GLIMMIX. 
Example codes are explained in detail for both procedures.  
The applied part of this thesis illustrates the theoretical part by fitting GEE-type models 
where the data are from a cluster-randomized study called IndiMed. The clusters are 
doctors who were randomized to intervention or control group and subjects are men with 
high blood pressure. All subjects in one cluster are either in intervention (received genetic 
risk information on the 2nd visit) or control group (received risk information on the 4th 
visit). Systolic and diastolic blood pressures were measured on all of the 5 planned visits. 
GEE modelling is done to compare the two groups. Finally, results and discussion is 
presented to conclude the findings.   
The author of this thesis would like to express gratitude to the supervisor Kristi Läll for 
being patient, motivating and guiding throughout the writing of this thesis. Thanks to 
supervisor Pasi Korhonen for critical comments and overall ideas and thanks to supervisor 
Krista Fischer from the Estonian Genome Center of University of Tartu for general 
comments and helping to direct. Final thanks to the whole IndiMed team for the data.   
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2. Generalized Estimating Equations (GEE) 
2.1 Introduction to Generalized Estimating Equations 
Longitudinal designs, which involve repeated measurements of a response variable in 
each subject, are often used in clinical trials and epidemiology. In clinical trials, repeated 
measurements are usually observed over a short period of time, whereas studies in 
epidemiology may last for many years. The interest in analysing longitudinal data is to 
describe the dependence of the outcome on predictor variables (marginal expectation of 
the outcome 𝑌 as a function of covariates 𝑋, i.e. 𝐸(𝑌|𝑋)). Repeated measurements tend 
to be correlated since they are made on the same subject. For example, two measurements 
from the same subject are likely to be more correlated than two measurements from 
different subjects. Since most statistical tests assume independence of observations, it is 
crucial to take the within-subject correlation into account to obtain correct statistical 
analysis. If we do not take the correlation into account, it can lead to a wrong test statistic 
and inference, for example standard errors will likely be too small. (Burton et al. 1998) 
(Zeger & Liang 1986) 
There are many techniques for analysis when outcome variable is approximately normally 
distributed (e.g. fitting growth curves for each subject using repeated measurements). 
When the outcome variable is not approximately normally distributed, there are fewer 
analysis methods available. Difficulty in analysis comes from the lack of multivariate 
joint distribution of the outcome variable, hence likelihood methods are not available or 
are difficult to compute. (Liang & Zeger 1986) 
Linear models for normally distributed data have been expanded to non-normal data using 
generalized estimation methods and quasi-likelihood when there is a single observation 
for each subject (no repeated measurements). Quasi-likelihood approach does not assume 
distribution, it only specifies a linear function between marginal expectation of the 
outcome variable and covariates and assumes that variance (of the outcome variable) is a 
known function of its expectation. (Zeger & Liang 1986) 
Generalized Estimating Equations are based on quasi-likelihood method of estimation. In 
addition to previously mentioned assumptions (expectation of outcome variable to be a 
linear function of covariates and that variance is a known function of the mean), one needs 
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to specify correlation structure between repeated measurements for each subject. The 
general idea is to incorporate the correlation structure between repeated measurements to 
get consistent estimators of coefficients and of their variances. (Zeger & Liang 1986) 
Before introducing GEE-type models, the next section will give the general idea of quasi-
likelihood estimator of which GEE is based on.  
 
2.2 Quasi-likelihood estimator 
This section is a short overview of quasi-likelihood used in GEE based on (Zeger & Liang 
1986). Quasi-likelihood is a methodology for regression that requires the specification of 
relationships between mean response and covariates and between mean response and 
variance. Thus it does not assume a probability distribution as in the case of full 
likelihood. 
Let 𝑌𝑖 be the response variable for each subject 𝑖 = 1, … ,𝑁 and 𝑋𝑖 be 𝑝 × 1 vector of 
covariates. Let 𝛽 be 𝑝 × 1 vector of regression parameters to be estimated. Define 𝜇𝑖 =
𝐸(𝑌𝑖|𝑋𝑖) to be the conditional expectation of 𝑌𝑖 and a function of covariates and regression 
parameters, so that  𝜇𝑖 = ℎ(𝑋𝑖
𝑇𝛽). The inverse of ℎ is the link function which relates the 
mean response to the linear predictor 𝑋𝑖
𝑇𝛽. For quasi-likelihood, variance of each 𝑌𝑖, 
denoted as 𝜐𝑖, is a known function of the expectation 𝜇𝑖, so that  𝜐𝑖 = 𝑓(𝜇𝑖) ∙ Φ. The scale 
parameter Φ is treated as a nuisance parameter. The quasi-likelihood estimator is the 
solution to the equations: 
𝑆𝑘(𝛽) = ∑
𝜕𝜇𝑖
𝜕𝛽𝑘
𝑁
𝑖=1 𝜐𝑖
−1(𝑌𝑖 − 𝜇𝑖) = 0, 𝑘 = 1,… , 𝑝. 
Estimators of regression parameters, ?̂?, are obtained by iteratively reweighted least 
squares method.  
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2.3 Marginal models  
A standard GEE is known as a marginal model. Marginal models extend generalized 
linear models to longitudinal data and are typically used when the inference is population-
based, rather than individual-based. The term “marginal” means that in the model 
specification the expected value of the response variable 𝑌, depends only on covariates 
(fixed effects) and does not depend on subject specific random effects nor directly on 
previous responses of the subject. Since the purpose is to describe the changes in 
population mean rather than changes within subjects, within-subject correlation is 
regarded as a nuisance characteristic. Regression parameters and within-subject 
correlation is modelled separately. (Fitzmaurice et al. 2004) 
Let’s introduce some notation for the repeated measurements. We have 𝑁 subjects who 
are measured repeatedly. 𝑌𝑖𝑗 denotes the response variable for the 𝑖
𝑡ℎ subject on the 𝑗𝑡ℎ 
measurement occasion. A realisation of each 𝑌𝑖𝑗 is observed at time 𝑡𝑖𝑗. The response 
variable can be continuous, binary, multinomial or a count. We assume the data are 
unbalanced (the number of repeated measurements can be different for subjects and/or 
they can be measured at different occasions) and that there are 𝑛𝑖 repeated measurements 
for the 𝑖𝑡ℎ  subject.  
The response variable is a 𝑛𝑖 × 1 vector 
𝑌𝑖 = (
𝑌𝑖1
𝑌𝑖2
⋮
𝑌𝑖𝑛𝑖
), 𝑖 = 1,… ,𝑁. 
𝑌𝑖 are assumed to be independent, but observations within the subject are not assumed to 
be independent. Associated with each response at a given time point 𝑗, there is a 𝑝 × 1 
vector of covariates 
𝑋𝑖𝑗 =
(
 
𝑋𝑖𝑗1
𝑋𝑖𝑗2
⋮
𝑋𝑖𝑗𝑝)
 , 𝑖 = 1,… ,𝑁; 𝑗 = 1,… , 𝑛𝑖 
which can be collected into a 𝑛𝑖 × 𝑝 matrix of covariates 
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𝑋𝑖 =
(
 
 
𝑋𝑖1
𝑇
𝑋𝑖2
𝑇
⋮
𝑋𝑖𝑛𝑖
𝑇
)
 
 
=
(
 
𝑋𝑖11 𝑋𝑖12 … 𝑋𝑖1𝑝
𝑋𝑖21
⋮
𝑋𝑖𝑛𝑖1
𝑋𝑖22
⋮
𝑋𝑖𝑛𝑖2
…
⋱
…
𝑋𝑖2𝑝
⋮
𝑋𝑖𝑛𝑖𝑝)
 , 𝑖 = 1,… ,𝑁. 
They can be either time-invariant or time-dependent. Time-invariant variable is fixed 
within a subject at the same value irrespective of time point 𝑗, whereas time-dependent 
variable is varying with time for each subject.  
 
The GEE requires the following specifications for a marginal model: 
1) Conditional mean of 𝑌𝑖𝑗  is related to covariates by a known link function, 
𝑔(𝜇𝑖𝑗) = 𝜂𝑖𝑗 = 𝑋𝑖𝑗
𝑇𝛽, 
where 𝜇𝑖𝑗 = 𝐸(𝑌𝑖𝑗|𝑋𝑖𝑗) is a conditional expectation (or mean) of the response 
variable and 𝛽 is a 𝑝 × 1 vector of regression parameters. 
2) The conditional variance of each 𝑌𝑖𝑗 may depend on the mean response, given the 
effects of covariates, as 
𝑉𝑎𝑟(𝑌𝑖𝑗) = 𝜙𝜐(𝜇𝑖𝑗) 
where the variance function 𝜐(𝜇𝑖𝑗) is a known function of the mean 𝜇𝑖𝑗 and 𝜙 is 
a scale parameter that may be known or may need to be estimated. For balanced 
longitudinal designs, a separate scale parameter, 𝜙𝑗, could be estimated at the 𝑗
𝑡ℎ 
occasion. Alternatively, 𝜙 could depend on the times of measurement, where 
𝜙(𝑡𝑖𝑗) is some parametric function of 𝑡𝑖𝑗. When the response is a continuous 
variable, then variance of each  𝑌𝑖𝑗 does not depend on mean response and is 
𝑉𝑎𝑟(𝑌𝑖𝑗) = 𝜙𝜐(𝜇𝑖𝑗) = 𝜙. Note that this assumes homogeneity of variance over 
time, which is often too strong of an assumption.    
 
3) Correlation among repeated measurements is a function of the means, 𝜇𝑖𝑗, and a 
set of parameters, 𝛼, which characterize the within-subject correlation and need 
to be estimated. The “working” covariance matrix for 𝑌𝑖 is given by 
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𝑉𝑖 = 𝐴𝑖
1
2𝑅𝑖(𝛼)𝐴𝑖
1
2 𝜙⁄ . 
Correlation matrices 𝑅𝑖(𝛼) can be different for subjects, however, it is fully 
specified by 𝛼, which is the same for all subjects. 𝐴𝑖 is a 𝑛𝑖 × 𝑛𝑖 diagonal matrix 
with 𝑔(𝜇𝑖𝑗) on the diagonal. “Working” covariance means that we do not know 
the true correlation structure between repeated measurements and are not 
assuming we are specifying it correctly. We would like to get consistent estimates 
of regression parameters regardless of the chosen structure.  (Fitzmaurice et al. 
2004) (Zeger & Liang 1986) 
 
2.4 Correlation structures 
Here we present five basic correlation structures (see Figure 7.1-1 in the appendix for 
illustration).  
 
Independence 
The most basic structure is independence, where each observation within a subject is 
uncorrelated with another observation. An example of a 4x4 correlation matrix with 
independence structure is the following 
𝑅𝐼𝑁 = (
1
0
0
1
0
0
0
0
0
0
0
0
1
0
0
1
), where 𝐶𝑜𝑟(𝑌𝑖𝑗, 𝑌𝑖𝑘) = {
1, 𝑖𝑓 𝑗 = 𝑘
0, 𝑖𝑓 𝑗 ≠ 𝑘
     
 
Exchangeable  
In exchangeable correlation structure, responses are assumed to be equally correlated 
within an individual.   
𝑅𝐸𝑋 = (
1
𝛼
𝛼
1
𝛼
𝛼
𝛼
𝛼
𝛼
𝛼
𝛼
𝛼
1
𝛼
𝛼
1
), where 𝐶𝑜𝑟(𝑌𝑖𝑗 , 𝑌𝑖𝑘) = {
1, 𝑖𝑓 𝑗 = 𝑘
𝛼, 𝑖𝑓 𝑗 ≠ 𝑘
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Autoregressive AR-1 
Two observations closer in time are correlated more than two observations more further 
in time. This structure is often used in longitudinal designs. Note that 𝑛𝑖 in this example 
is 4. 
𝑅𝐴𝑅−1 = (
1  𝛼   𝛼2 𝛼3
𝛼   
𝛼2
𝛼3
1  
𝛼   
𝛼2
𝛼   
1  
𝛼   
𝛼2
𝛼   
1  
), where 𝐶𝑜𝑟(𝑌𝑖𝑗, 𝑌𝑖,𝑗+𝑡) = 𝛼
𝑡, 𝑓𝑜𝑟 𝑡 = 0, . . , 𝑛𝑖 − 𝑗. 
 
Toeplitz 
Correlation is the same for any two observations that have the same distance in time. Note 
that 𝑛𝑖 in this example is 4. 
𝑅𝑇𝑂𝐸𝑃 = (
1
𝛼1
𝛼1
1
𝛼2
𝛼1
𝛼3
𝛼2
𝛼2
𝛼3
𝛼1
𝛼2
1
𝛼1
𝛼1
1
), where 𝐶𝑜𝑟(𝑌𝑖𝑗, 𝑌𝑖,𝑗+𝑡) = {
1,    𝑖𝑓 𝑡 = 0                 
𝛼𝑡, 𝑖𝑓 𝑗 = 1, . . , 𝑛𝑖 − 𝑡
 
 
Unstructured 
There is no assumption made about any two observations within a subject, so correlation 
can take a value between -1 and 1. This type of correlation is the most flexible one, but 
the number of parameters can become too high very quickly.  
𝑅𝑈𝑁 = (
1
𝛼12
𝛼12
1
𝛼13
𝛼23
𝛼14
𝛼24
𝛼13
𝛼14
𝛼23
𝛼24
1
𝛼34
𝛼34
1
), where 𝐶𝑜𝑟(𝑌𝑖𝑗, 𝑌𝑖𝑘) = {
1,     𝑖𝑓 𝑗 = 𝑘
𝛼𝑗𝑘, 𝑖𝑓 𝑗 ≠ 𝑘
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2.5 Estimation of parameters 
The GEE estimator is the solution of the system 
∑ 𝐷𝑖
𝑇𝑉𝑖
−1𝑆𝑖
𝑁
𝑖=1 = 0, 
where 𝑆𝑖 = 𝑌𝑖 − 𝜇𝑖 with 𝜇𝑖 = (𝜇𝑖1, … , 𝜇𝑖𝑛𝑖)
𝑇 and 𝐷𝑖 =
𝜕𝜇𝑖
𝜕𝛽
. Equations reduce to quasi-
likelihood equations when there is only one measurement for the outcome variable (𝑛𝑖 =
1) for each subject. Since estimating equations depend on 𝛽 and correlation parameter 𝛼, 
and generally have no closed-form solution, solving is based on a two-stage iterative 
method. (Zeger & Liang 1986) 
Parameters of 𝛽 are estimated by solving the equation starting with 𝜙 = 1 and 𝑅𝑖 as an 
identity matrix. Estimates are used in calculating fitted values ?̂?𝑖 = 𝑔
−1(𝑋𝑖
𝑇𝛽) and 
residuals 𝑦𝑖 − ?̂?𝑖. These are used to estimate 𝐴𝑖, 𝑅𝑖 and 𝜙. Then these steps are repeated 
to improve ?̂? until convergence.  
One of the properties of GEE estimator is that the estimate of 𝛽 is consistent even when 
assumed correlation structure among repeated measurements is not correct. That is, ?̂? has 
the property of being close to the true parameter 𝛽 in large samples. The unbiasedness of 
the parameter estimates only depends on the correct specification of the model for mean 
response.  
 
2.6 Sandwich estimator 
The following section is based on (Fitzmaurice et al. 2004). 
In the GEE context, usual standard errors of 𝛽 are not valid when correlation structure 
among repeated measurements is misspecified (even though the estimate of 𝛽 is 
consistent). The variance of the GEE estimator of 𝛽 can be made robust to the 
misspecification of correlation structure (in a sense that it provides valid standard errors 
when correlation structure is not correct) by incorporating the empirical variance 
estimator, called “sandwich” covariance estimator (Diggle et al. 2002).  The robustness 
of sandwich variance estimator is asymptotic meaning that it is a large sample property. 
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If the sample size is large, the sampling distribution of ?̂? is multivariate normal 
distribution with mean 𝛽 and covariance in the form of 
𝐶𝑜𝑣(?̂?) = 𝐵−1𝑀𝐵−1 
where 𝐵−1 = (∑ 𝐷𝑖
𝑇𝑉𝑖
−1𝑁
𝑖=1 𝐷𝑖)
−1
  and 𝑀 = ∑ 𝐷𝑖
𝑇𝑉𝑖
−1𝑁
𝑖=1 𝐶𝑜𝑣(𝑌𝑖)𝑉𝑖
−1𝐷𝑖. 
The covariance of ?̂? can be estimated by the “sandwich” estimator 
Σ̂𝑆 ∶= 𝐶𝑜?̂?(?̂?) = (∑ ?̂?𝑖
𝑇
?̂?𝑖
−1𝑁
𝑖=1 ?̂?𝑖)
−1
∑ ?̂?𝑖
𝑇
?̂?𝑖
−1𝑁
𝑖=1 (𝑌𝑖 − ?̂?𝑖)(𝑌𝑖 −
?̂?𝑖)
𝑇?̂?𝑖
−1
?̂?𝑖 (∑ ?̂?𝑖
𝑇
?̂?𝑖
−1𝑁
𝑖=1 ?̂?𝑖)
−1
, 
where 𝛼, 𝜙 and 𝛽 have been replaced by their estimates in 𝐵 and 𝑀, and 𝐶𝑜𝑣(𝑌𝑖) has 
been replaced with (𝑌𝑖 − ?̂?𝑖)(𝑌𝑖 − ?̂?𝑖)
𝑇 in 𝑀. 
The model-based covariance estimator is  
𝐶𝑜?̂?(?̂?) = ?̂?−1 = (∑ ?̂?𝑖
𝑇
?̂?𝑖
−1𝑁
𝑖=1 ?̂?𝑖)
−1
  
and it yields valid standard errors when the working correlation is correctly specified.  
The use of sandwich estimator ensures that parameter estimates are consistent even 
though the working correlation structure may not be correct. However, a correct structure 
can increase efficiency (Burton et al. 1998). It has been shown that misspecification of 
the correlation structure can reduce efficiency and inflate variance estimates (Wang & 
Carey 2003). Therefore, it is important to try to choose the structure which is close to the 
true correlation matrix 𝑅𝑖(𝛼). Since one of the aims of fitting a model is to estimate the 
parameters which describe the correlation structure, one should choose it before the 
analysis (Burton et al. 1998).  
GEE approach assumes data to be missing completely at random (MCAR, (Rubin 1976), 
(Laird n.d.)), meaning that the missingness does not depend on observed or unobserved 
responses. If the data are missing at random (MAR), then GEE method can lead to biased 
results.  
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2.7 Model inference and interpretation of parameters 
Interpretation of regression coefficients depend on the link function used in modelling. 
Since within-subject correlation is estimated from residuals, parameter estimates are 
interpreted in a population-average manner. Formal inferences (statistical significance 
tests) and parameter estimates’ confidence intervals are based upon Wald test. Regression 
coefficient estimates are divided by their robust (empirical) standard error and the results 
are treated as Normal standardized deviates (Z statistic). (Burton et al. 1998). It can 
underperform when sample size is small. Contrasts for a type III test of hypothesis can be 
tested with generalized score tests.  
 
2.8 Quasi-likelihood Information Criterion (QIC) 
Well-known model selection criteria such as Akaike Information Criterion (AIC) or 
Bayesian Information Criterion (BIC) cannot be applied here since these are likelihood-
based and full multivariate likelihood is not used in GEE modelling. However, there is a 
criterion proposed by (Pan 2001) which is based on AIC but with quasi-likelihood 
approach, constructed under independence working correlation structure. This quasi-
likelihood information criteria (QIC) for GEE models is in the form of 
𝑄𝐼𝐶(𝑅) = −2𝑄(?̂?(𝑅), 𝐼, ∆) + 𝑡𝑟(Σ̂𝑀(𝐼𝑁)
−1 Σ̂𝑆(𝑅)), 
where 𝑄(?̂?(𝑅), 𝐼, ∆) is the quasi-likelihood under the assumption of working correlation 
matrix 𝑅, Σ̂𝑀(𝐼𝑁)
−1  is the model-based covariance estimator under independence working 
correlation structure assumption, Σ̂𝑆(𝑅) is the sandwich covariance estimator under the 
working correlation structure 𝑅 and 𝑡𝑟 is the notation for matrix trace. (Jang 2011) 
Different models are comparable in the same way as when using AIC – model with 
smaller QIC value is preferred.   
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2.9 Summary of GEE 
In summary, the GEE approach is a widely used method of estimation in longitudinal 
designs. Instead of modelling the covariance among repeated measurements, GEE treats 
it as a nuisance and models the mean response. Covariances and standard errors are valid 
under the assumption of data missing completely at random.   
The GEE has many appealing properties and is often the preferred method for the 
following reasons. Firstly, even when within-subject correlation structure is not close to 
the true underlying correlation structure, the GEE estimator ?̂? still gives a consistent 
estimate. Secondly, the usual standard errors are not valid when correlation structure is 
misspecified, therefore sandwich estimator of 𝐶𝑜𝑣(?̂?) can be used to get valid standard 
errors. Finally, it is not crucial to assume multivariate normal or any other distribution for 
the outcome. One needs to specify only the first two moments. The validity of GEE 
estimates, ?̂?, rely only on specifying the correct model for mean response.  
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3. Using GEE method of estimation in SAS 
In this section, two procedures for estimating parameters with GEE in SAS: PROC 
GENMOD and PROC GLIMMIX are presented. The following chapter is based on SAS 
User’s Guide (SAS Institute Inc. 2011), where more options are available.  
 
3.1 PROC GENMOD 
The GENMOD procedure fits generalized linear models, where it is needed to specify the 
link function and the probability distribution of the response variable. The following 
example code will be discussed in detail.  
PROC GENMOD DATA=data DESCENDING; 
CLASS x1(REF='1') id /PARAM=ref; 
MODEL y=x1 x2 x1*x2 /LINK=identity DIST=normal TYPE3 WALD; 
REPEATED SUBJECT=id /WITHINSUBJECT=timepoints TYPE=ar(1) CORRW CORRB; 
RUN;  
Note that 𝑦 is the response variable, 𝑥1 and 𝑥2 are the covariates. Each distinct value of 
the subject-effect (𝑖𝑑) identifies a different subject and each distinct value of the within 
subject-effect (𝑡𝑖𝑚𝑒𝑝𝑜𝑖𝑛𝑡𝑠) defines a different outcome for the same subject.  
PROC GENMOD statement invokes the procedure. DESCENDING option sorts the 
response variable from highest to lowest (useful with binary and multinomial outcomes).  
CLASS statement lists all categorical variables and must be before the MODEL 
statement. PARAM=REF and REF=’level’ need to be specified to be able to use a custom 
reference level.  
MODEL statement specifies the response variable (numeric or character) and covariates 
(also numeric or character). An intercept is added to the model by default. LINK states 
the link function and DIST states the probability distribution to be used for 𝑌 in the model. 
If those are omitted, the model defaults to normal distribution with identity link function. 
TYPE3 computes generalized score statistics for GEEs and WALD calculates Wald 
statistics for Type III contrasts (only computed when TYPE3 is specified as well) using 
empirical (robust) variance estimators.  
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REPEATED statement invokes the GEE method and specifies the covariance structure of 
repeated measurements in the model. SUBJECT can be a single effect, interaction or 
nested and must be listed in the CLASS statement. WITHINSUBJECT defines an effect 
that specifies an order of repeated measurements. If for example there are some missing 
values, then specifying WITHINSUBJECT effect, the repeated measurements are ordered 
in a correct way (missing values are not assumed to be the last measurements). TYPE is 
used to specify the working correlation matrix. CORRW displays the estimated working 
correlation matrix and CORRB displays the regression parameter estimates’ correlation 
matrix (empirical and model-based matrices are presented).  
To address the missing completely at random assumption of GEE-type models, the 
GENMOD procedure can estimate the working correlation by using all available pairs 
method, and the obtained covariances and standard errors are valid under the MCAR 
assumption. (SAS User guide). There is an option to use weighted GEE method available 
in PROC GEE (in SAS version 13) which provides consistent estimates when data are 
missing at random (MAR) (SAS Institute Inc. 2014). 
 
3.2 PROC GLIMMIX 
This procedure can also fit GEE-type models, but there is an additional option to 
incorporate random effects. An example of GEE approach in the GLIMMIX procedure:  
PROC GLIMMIX DATA=data EMPIRICAL; 
CLASS x1 id x3; 
MODEL y=x1 x2 x1*x2 /LINK=identity DIST=normal SOLUTION; 
RANDOM timepoints /SUBJECT=id TYPE=ar(1) RESIDUAL; 
RANDOM intercept /SUBJECT=id(x3); 
RUN; 
PROC GLIMMIX invokes the procedure. The EMPIRICAL option requests the sandwich 
estimator to be used in calculating covariances for fixed effects.  
CLASS statement like in the previous example lists all the categorical variables and must 
be before the MODEL statement.  
MODEL statement names the response variable and covariates. An intercept is added by 
default. Adding the option SOLUTION produces the scale parameter and parameter 
estimates for fixed effects.  
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RANDOM statement invokes the GEE when used with RESIDUAL option. The 
𝑡𝑖𝑚𝑒𝑝𝑜𝑖𝑛𝑡𝑠 effect is specified when there’s a need to order the columns of covariance 
structure by the time variable. SUBJECT option identifies the subjects in the model. All 
subjects are assumed to be independent from each other. Adding the subject effect nests 
all the other effects in the RANDOM statement within the subject effect. TYPE specifies 
the covariance structure in the same way as in the GENMOD procedure. 
To incorporate random effects in to the model, one needs to specify it with another 
RANDOM statement, for example if a variable 𝑥3 is a random effect, specifying 
RANDOM intercept /SUBJECT=id(x3); 
 
will treat 𝑥3 as a random effect and assumes subjects are nested within the random effect. 
Note that with the EMPIRICAL option, adding any random effects requires that data are 
grouped by subjects.  
For the differences between PROC GENMOD and PROC GLIMMIX, refer to appendix 
7.2. 
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4. Analysis of the IndiMed trial 
This section will give an overview of IndiMed study design, some descriptive statistics 
of the data and results of analysis using GEE method of estimation. 
  
4.1 IndiMed study design 
The following section is a summary from an article (Meren et al. 2015). 
Cardiovascular diseases (CVD) are the number one cause of death in Estonia. One of the 
risk factors of cardiovascular diseases is an increased arterial blood pressure which is 
most often caused by hypertension (HT). The incidence rate of HT has been 1400-1500 
per 100 000 persons in Estonia from 2010-2013. Incidence of the disease is significantly 
higher after turning 35 years old and highest in 45-64-year old men.   
HT is treatable by medication when good adherence can be achieved. Unfortunately, 
25%-60% of HT patients will stop taking medication within the first 6 months of 
treatment. Low treatment adherence may be caused by disease’s long asymptomatic 
period, complicated treatment scheme, ignorance of the disease, scepticism of treatment 
efficacy and high price of medications. 
The heritability of cardiovascular disease mortality is estimated to be 38-57%, being 
different for males and females. Genetic markers tied to risks of CVD have been identified 
and different risk scores have been calculated using those markers. Results of analysis of 
the data from the Estonian Genome Center of University of Tartu have been shown that 
those risk scores are usable in Estonian population. For example, male gene donors in 
high risk score group have been shown to have 1.9 (95% CL 1.5-2.5) times higher risk 
for ischemic heart disease than in low risk score group. 
It is not known how information about personal genetic risks affect HT patients’ 
behaviour. The primary objective of IndiMed study is to estimate the effect of personal 
genetic risk information to patients’ medication adherence and treatment efficiency.  
The study is based on comparison of two groups – intervention and control. Control group 
consists of patients who get HT treatment and counselling in the standard way, according 
to the national guidelines. The intervention group patients get the same treatment as 
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control group, but additionally they receive information about their genetic risks of four 
diseases (type 2 diabetes, coronary artery disease, stroke, atrial fibrillation) according to 
the genetic risk scores. The information is communicated to them by their physician. After 
treatment start, data on treatment adherence, effectiveness of treatment, body weight and 
smoking habits are collected from both groups. The difference between systolic and 
diastolic blood pressure in two groups will be used to draw conclusions about 
effectiveness of receiving information on genetic risks.  
This study is cluster-randomized and there was no blinding of patient and physician. The 
clusters are physicians who were randomized to intervention and control. Informing 
patients about their personal risk scores was thought to affect physician’s behaviour 
towards the patients who did not receive risk score information and therefore decrease 
the differences of the study groups. For this reason, all of the patients in a physician’s 
care are in the same study group (intervention or control).  
The subjects are 18 to 65-year-old males with 1st or 2nd grade hypertension who did not 
get medications for HT in the past two months (before entering the study). Duration of 
patient’s participation in the study is 12 months which includes 5 visits. See appendix 7.3 
for the study design figure, including the timeline of the visits and what was measured.  
Patient’s blood sample was taken during the first visit.  From the blood sample, DNA was 
separated and genotyped in EGCUT lab using real-time PCR method. Using known 
genetic markers (according to published large-scale Genome-Wide Association Studies, 
GWAS), personal risk scores were calculated for the following diseases: type 2 diabetes, 
coronary artery disease, stroke and atrial fibrillation (arrhythmia). For each disease state 
a patient was classified into one of the two categories: high genetic risk group (highest 
10% of risk scores) or an average genetic risk group. The choice of these diseases was 
motivated by the fact that patients with HT are at high risk for these conditions and also 
by the existing knowledge on genetic markers affecting the risk. 
During the next visits, treatment adherence was evaluated using Morisky Medication 
Adherence Scale (Morisky et al. 1986) and Brief Medication Questionnaire (Svarstad et 
al. 1999) allowed to describe the problems encountered while taking medication. Change 
in arterial systolic blood pressure during the study measured treatment effectiveness. 
Patient’s health behaviour change was evaluated from body weight and smoking habits 
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(number of cigarettes per day). The difference in study groups come from visits 2 and 4 
where the physician gave information about personal risk scores (intervention group 
received risk information on 2nd visit and control on 4th visit). The purpose of last (5th) 
visit was to evaluate long-term changes in patient’s risk behaviours.  
 
4.2 Descriptive statistics 
There were 240 patients of whom 127 were in intervention group and 113 were in control 
group (Table 4.2-1). There were in total 34 doctors of whom 76% had 6 or fewer patients.  
Table 4.2-1 Number of patients in intervention and control group. 
Group N % 
Intervention 127 52.9 
Control 113 47.1 
Total 240 100.0 
 
Most of the patients (45.8%) belong to the high risk group for one of the four diseases 
(Table 4.2-2, note that per cents are based on total 𝑁). On the other hand, nobody had the 
high risk for all four diseases.  
Table 4.2-2 Number of conditions with high genetic risk among subjects by study group. 
Risk 𝑵𝒐 𝒉𝒊𝒈𝒉 𝒓𝒊𝒔𝒌𝒔 𝟏 𝒉𝒊𝒈𝒉 𝒓𝒊𝒔𝒌 𝟐 𝒉𝒊𝒈𝒉 𝒓𝒊𝒔𝒌𝒔 𝟑 𝒉𝒊𝒈𝒉 𝒓𝒊𝒔𝒌𝒔 
Group 𝑵 % 𝑵 %  𝑵 % 𝑵 % 
Intervention 39 16.3 61 25.4 25 10.4 2 0.8 
Control 42 17.5 49 20.4 17 7.1 5 2.1 
Total 81 33.8 110 45.8 42 17.5 7 2.9 
 
All subjects were between 18 to 65 years old at the time of the first visit with mean weight 
of 94.3 kilograms, mean height of 179.4 centimeters and mean Body Mass Index (BMI, 
calculated as 𝐵𝑀𝐼 =
𝑤𝑒𝑖𝑔ℎ𝑡
ℎ𝑒𝑖𝑔ℎ𝑡2/100
) of 29.2 (Table 4.2-3Table 4.2-3).   
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Table 4.2-3 Descriptive statistics for subjects’ age, weight, height and BMI. 
 Age Weight (kg) Height (cm) BMI 
N 240 240 239 239 
Mean 41.5 94.3 179.4 29.2 
Median 42 92 179 28 
SD ∗ 12.15 17.51 7.70 4.67 
Min 18 56 161 20 
Max 65 155 202 43 
 ∗ Standard deviation calculated as 𝑆𝐷 = √
1
𝑁−1
∑ (𝑥𝑖 − ?̅?)2
𝑁
𝑖=1 , where 𝑁 is the number of nonmissing 
values of 𝑥. 
 
For blood pressure related studies, risk factors are typically age, BMI and smoking. It is 
known that regularly smoking increases blood pressure and for this reason smoking is 
considered as a risk factor. Most of the patients (61.25%) were non-smokers (Table 7.4-1 
in the appendix). Blood pressure could be associated with education level, meaning that 
subjects with higher education level are following the treatment more carefully and 
therefore have lower blood pressure by the end of the study. Education is also added into 
the models in the analysis section. Frequencies of patients’ completed education level by 
study group is displayed in Table 7.4-2 in the appendix.  
The following figures (Figure 4.2-1 and Figure 4.2-2) present systolic and diastolic blood 
pressure box plots by each visit for intervention and control group. In Figure 4.2-1, mean 
systolic blood pressure in intervention group drops noticeably with three visits. 
Variability is quite high in both study groups. In Figure 4.2-2, variability and mean 
diastolic blood pressure in intervention group seem to be a bit smaller than in the control 
group. 
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Figure 4.2-1 Box plots of systolic blood pressure by study group and visit. Note that + 
and Ο inside the boxes display the means and outside the boxes display outliers. 
 
Figure 4.2-2 Box plots of diastolic blood pressure by study group and visit. Note that + 
and Ο inside the boxes display the means and outside the boxes display outliers. 
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Response variables, which are systolic and diastolic blood pressures, are assumed to be 
normally distributed in the population. However, IndiMed data are a sample of subjects 
with higher blood pressure than in the general population, therefore the distribution is 
skewed to the right as depicted below. 
 
Figure 4.2-3 Distribution of systolic blood pressure over all visits and subjects. 
Transforming the response variable may help to fix the skewedness. After log-
transformation, systolic blood pressure is approximately normally distributed (Shapiro-
Wilk statistic p-value 0.23) as shown in Figure 7.5-1 in the appendix. 
For diastolic blood pressure (see Figure 7.5-2), neither log or square root transformations 
were successful according to the Shapiro-Wilk statistic. However, Box-Cox test, which 
helps to find a power transformation gave log-transformation as the best candidate. 
Therefore, we will also use log-transformed diastolic blood pressure in analysis (see 
Figure 7.5-3 for the shape of distribution).   
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4.3 Analysis  
One of the aims of the analysis is to assess the effect of receiving genetic risk information 
on blood pressure. For this part, intervention and control groups are compared. The 
hypothesis is that for at least one blood pressure measure (systolic or diastolic), 
intervention and control groups are statistically different.  
Secondly, is there a difference in blood pressure depending on whether the patients who 
got feedback on genetic risks actually had a high risk for one or more diseases? For this 
part, intervention group subjects are divided into two groups by the genetic risk: a) no 
diseases with high genetic risk, b) at least one disease with high genetic risk. The third 
group will be all patients in the control group. The hypothesis is that there is a difference 
in mean blood pressure between those three groups.  
Since the patients are clustered by doctors, ideally the model should capture a random 
effect of the doctor, because we want to assume the doctors are randomly chosen from 
the whole population of doctors. To focus on GEE rather than GEE with additional 
random effects, the main analysis here will be done assuming a fixed doctor effect by 
using the GENMOD procedure in SAS. After that, assuming a random doctor effect, the 
GLIMMIX procedure which allows to add random effects together with GEE, is used.  
Taking into account the characteristics of the data and how it is collected, AR-1 type of 
correlation structure between repeated measurements is assumed. Note that other 
(independent, exchangeable and Toeplitz) correlation structures were tested, but overall 
AR-1 gave lower QIC. 
The GEE assumes missing values in data to be missing completely at random. There are 
many subjects with the last visit information missing at the time of the analysis (Table 
7.4-3 in the appendix) and therefore only first four visits are used. The procedure 
GENMOD assumes MCAR data, but the data are more likely to be missing at random. 
Therefore, the estimates may be biased.  
All models are fit for both systolic and diastolic blood pressures, where these variables 
are log-transformed beforehand to fix skewedness of the distribution. 
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Let’s present an example of a log-linear (response is log-transformed and covariates are 
in the original scale) model’s interpretation of parameter estimates.   
Let the model for the blood pressure and estimated parameters be in the form of 
𝑙𝑜𝑔(𝐵𝑃) = 4.49 − 0.03 ∙ 𝑔𝑟𝑜𝑢𝑝(𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛) − 0.08 ∙ 𝑣𝑖𝑠𝑖𝑡(2) − 0.10 ∙ 𝑣𝑖𝑠𝑖𝑡(3) − 0.11 ∙
𝑣𝑖𝑠𝑖𝑡(4)  
Then the interpretation of mean blood pressure depends on the reference levels. Here the 
reference levels are 𝑔𝑟𝑜𝑢𝑝 = 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 and 𝑣𝑖𝑠𝑖𝑡 = 1. The (geometric) mean blood 
pressure at the reference levels is 𝑒4.49 = 89.12. Mean blood pressure at visit 1 for 
intervention group is 𝑒(4.49−0.03) = 86.5. The means are different for intervention and 
control depending on the visits, but the ratio stays the same and is 𝑒𝑒𝑓𝑓𝑒𝑐𝑡 = 𝑒(−0.03) =
0.97. It is convenient to interpret the differences between the two groups in terms of 
relative change. In this example, switching from control to intervention, the mean blood 
pressure is expected to decrease by about 3%.   
Lastly, we have to consider multiple comparison since we are testing both systolic and 
diastolic blood pressures. Using Bonferroni correction, the significance level of parameter 
estimates is at 𝛼 = 0.025 (0.05/2 = 0.025). However, it can be argued that for systolic 
and diastolic blood pressures this correction is too strict because there is a strong 
correlation among the response variables (𝐶𝑜𝑟(𝑠𝑦𝑠𝑡𝑜𝑙𝑖𝑐, 𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐) = 0.71). 
 
4.3.1 Intervention vs control group  
The following three types of models (of form in section 2.3) for log-transformed systolic 
and diastolic blood pressures were fitted. Note that group variable is always included in 
the models, even if nonsignificant, because hypotheses are based on that variable.  
 
1)  𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝  
This model compares the overall mean blood pressure (across all visits) of the two study 
groups. For diastolic blood pressure (DBP), the parameter estimates are in the table 
below.   
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Table 4.3-1 Analysis of GEE parameter estimates, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝. 
Response Parameter Estimate SE Z p-value 
Diastolic Intercept 4.4890 0.0072 625.89 <.0001 
 Group (Intervention) -0.0297 0.0094 -3.18 0.0015 
 
According to the analysis, there is a significant difference in control and intervention 
group (𝑝 = 0.0020, see in Table 7.6-3). The geometric mean of the diastolic blood 
pressure in the control group is 𝑒4.4890 = 89.03  and for the intervention group it is 
𝑒4.4890−0.0297 = 𝑒4.4593 = 86.43 (over all 4 visits). If the patient receives genetic risk 
information, we see about 2.9% lower geometric mean of the diastolic blood pressure. 
For the systolic blood pressure (see Table 7.6-1 and Table 7.6-2), the group variable is 
nonsignificant at 𝛼 = 0.025 level (?̂? = −0.0136, 𝑝 = 0.0878). 
 
2) 𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟 
This model assumes the mean blood pressure depends on the groups, visits and doctors.  
In the model with diastolic blood pressure as response (Table 7.6-6 and Table 7.6-7), the 
group variable (𝑝 = 0.2694) is nonsignificant. The effect of visit as well as that of the 
doctor are significant. Compared to visit 1, we see about 8.1% decrease in the geometric 
mean of diastolic blood pressure in visit 2 and about 10.5% decrease in blood pressure in 
visit 4.  
For systolic blood pressure (Table 7.6-4 and Table 7.6-5), the doctor’s effect (𝑝 =
0.5121) and group’s effect (𝑝 = 0.0559) were nonsignificant.  
 
3) 𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟 + 𝐵𝑀𝐼 + 𝑎𝑔𝑒 + 𝑠𝑚𝑜𝑘𝑖𝑛𝑔 + 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛  
This model is similar to the above one, but also including some additional risk factors. 
These are added to account for the associations which may distort the real relationship 
between response variable and covariates. When modelling blood pressure, often the risk 
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factors are BMI and age because higher BMI and older age refer to higher risk of HT. In 
addition, risk of HT can increase due to smoking. It is possible that patients at higher 
education level are following the treatment better than patients at lower education level 
and therefore have lower blood pressure by last visits. For this reason, education level is 
also included as a covariate.  
This model will be fit first by treating doctor as a fixed effect and then treating it as a 
random effect. Note that the other risk factors are not removed from the model, even if 
nonsignificant, because we want to control for them. 
In the model for diastolic blood pressure (Table 7.6-10 and Table 7.6-11), group is again 
nonsignificant (𝑝 = 0.2045), therefore there is no evidence for mean blood pressure 
difference between intervention and control groups. Education is also nonsignificant. 
BMI, smoking and age all have positive parameter estimates, meaning that high BMI, 
older age and smoking increase mean blood pressure. For visits the effects are very similar 
to the previous model 2).  
In the random effect model for diastolic blood pressure (Table 7.6-14 and Table 7.6-15), 
education is nonsignificant as in the above model. However, there is a significant group 
effect (𝑝 = 0.0024). Parameter estimates for visit are very similar to the fixed effect 
model.  
In systolic blood pressure model (Table 7.6-8 and Table 7.6-9), there is no difference in 
mean blood pressure between intervention and control. Only visit and BMI are significant 
with p-values of < 0.0001 and 0.0004 respectively. Visit effects are similar to the above 
model 2) and higher BMI has a positive parameter estimate which means that higher BMI 
refers to higher mean blood pressure.  
In random effect model for systolic blood pressure (Table 7.6-12 and Table 7.6-13, group 
is nonsignificant as it is in the fixed effects model. In addition to visit and BMI, education 
and age are significant variables.   
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4.3.2 Comparison of intervention group individuals with high genetic risk to 
individuals at low risk and to the control group 
 
In the next section, mean blood pressure is assessed in subgroups. The following model 
is fitted: 
𝑙𝑜𝑔(𝑌)~𝑠𝑢𝑏𝑔𝑟𝑜𝑢𝑝. 
The subgroup variable used in the model has a value: 
 0, if patient is in control group,  
 1, if patient is in intervention group and has no high genetic risks reported, 
 2, if patient is in intervention group and has high genetic risk for at least one 
disease reported.  
 
Table 4.3-2 Subgroup comparison for diastolic blood pressure. Model 
𝑙𝑜𝑔(𝑌)~𝑠𝑢𝑏𝑔𝑟𝑜𝑢𝑝. 
Response Parameter Estimate SE Z p-value 
Diastolic Intercept 4.4890 0.0072 625.81 <.0001 
 Subgroup (1) -0.0471 0.0117 -4.02 <.0001 
 Subgroup (2) -0.0217 0.0104 -2.08 0.0371 
 
For diastolic blood pressure (Table 4.3-2 above), subgroup effect is significant (𝑝 =
0.0010, see Table 7.6-17 in the appendix). Compared to control, intervention subgroup 2 
does not have statistically different mean diastolic blood pressure. We see about 4.7% 
decrease in mean blood pressure if the patient receives information on having no high 
genetic risks for any of the diseases. For subgroup 2, the decrease is about 2.2%. This 
model has a higher QIC than in model 1) in section 4.3.1 (QICs are 910.8 and 909.1 
respectively). 
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Table 4.3-3 Subgroup comparison for systolic blood pressure. Model 
𝑙𝑜𝑔(𝑌)~𝑠𝑢𝑏𝑔𝑟𝑜𝑢𝑝. 
Response Parameter Estimate SE Z p-value 
Systolic Intercept 4.9561 0.0061 815.90 <.0001 
 Subgroup (1) -0.0333 0.0102 -3.28 0.0010 
 Subgroup (2) -0.0044 0.0087 -0.51 0.6109 
 
For systolic blood pressure (Table 4.3-3 above and Table 7.6-16 in the appendix), 
subgroup effect is significant (𝑝 = 0.0079). The lowest mean systolic blood pressure is 
(as in the same model with diastolic blood pressure) for patients who received genetic 
risk information and had no high risks. Compared to control group patients, their mean 
blood pressure is decreased by about 3.3%. The difference between mean blood pressure 
between control group and subjects in intervention group who had at least one high 
disease risk, is nonsignificant. This model also does not have a better fit with the data 
than model 1) in section 4.3.1 (QIC 908.7 and 907.6 respectively), so it seems that 
whether or not one receives genetic risk information counts more than what their genetic 
risks are.   
In conclusion for this section, the model which estimates the mean blood pressure for 
intervention and control group is a better fit to the data than the model where the number 
of high genetic risks in the intervention group is also taken into account.  
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4.4 Discussion 
The mean blood pressure for intervention and control was not statistically different in 
most of the fitted models, so it implies that overall, it does not matter whether a patient 
knows or does not know if they have some high risks for the four diseases (type 2 diabetes, 
coronary artery disease, stroke and atrial fibrillation). It might be that at first, patients 
who know their personal risks, are worried and will take medication carefully, but after a 
while will accept it (or simply do not care) and the effect will fade in time. However, for 
diastolic blood pressure the effect is significant for model 1 in section 4.3.1. It is 
intriguing that systolic and diastolic blood pressures seem to respond differently. 
Subgroup analysis results indicate that control group (all subjects) and intervention group 
with at least one high disease risk do not have statistically different mean blood pressures. 
However, the effect between control and intervention (patients with no high risks) is 
statistically significant. This is surprising and the reasoning behind that needs further 
research. It might be that patients who know they have many high disease risks are trying 
to change their lifestyle and carefully follow medication, but have higher blood pressure 
for some other reason (for example they are less respondent to treatment or have 
genetically higher blood pressure). It would also be interesting to know whether mean 
blood pressures are different for a specific disease risk.   
In the near future, when all 5 visits have happened for all patients (at the time of the 
analysis not all patients had had their last visit), treatment adherence should also be 
analysed alongside with when and why the subject discontinued the study.   
Finally, one should notice that the sample size for this pilot study is rather small. The 
initial number of patients desired was 300, but only 240 patients joined the study. It is 
possible that the intervention had an effect, but it was too small to be discovered in this 
trial. Also the point estimates of the parameters in this study suggest a possibility of a 
beneficial effect of the intervention. Larger study is necessary to confirm the usefulness 
of genetic feedback.   
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5. Conclusion 
This thesis gave an overview of Generalized Estimating Equations, which is a method of 
estimation that accounts for correlations among repeated measurements and is widely 
used in longitudinal analysis. It has many appealing properties, mainly the robustness to 
misspecification of correlation structure between the repeated measurements. The validity 
of GEE parameter estimates and standard errors rely only on specifying the correct model 
for mean response.  
The general guidelines of how to implement GEE-type models was presented in section 
3 using SAS procedures PROC GENMOD and PROC GLIMMIX.  
The final section implemented GEE-type models on a cluster-randomized study called 
IndiMed, using data from the Estonian Genome Center of University of Tartu. The 
clusters are doctors who were randomized to intervention or control group and subjects 
are men with high blood pressure. All subjects in one cluster are either in intervention 
(received genetic risk information on the 2nd visit) or control group (received risk 
information on the 4th visit). Systolic and diastolic blood pressures were compared for 
the two study groups. Autoregressive AR-1 correlation structure was assumed for the 
repeated measurements of response variables.  
The mean blood pressure was not statistically significant for the two study groups in most 
of the fitted models which indicates there is no difference if the patient received personal 
risk information or not. The mean blood pressure was statistically different for patients in 
control group and patients in intervention group who had no high risks. Control group 
and intervention group patients with at least one high risk did not have statistically 
different means for blood pressure. These findings are quite surprising and suggest further 
analysis should be done. Future research can provide answers to questions whether there 
are some important factors which determine the blood pressure regarding if patient knows 
or does not know their risks for diseases.  
 
  
32 
 
6. References 
Burton, P., Gurrin, L. & Sly, P., 1998. Extending the simple linear regression model to 
account for correlated responses: an introduction to generalized estimating 
equations and multi-level mixed modelling. Statistics in medicine, 17(11), 
pp.1261–91. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9670414 
[Accessed April 9, 2016]. 
Diggle, P.J. et al., 2002. Analysis of Longitudinal Data Second edi., New York: Oxford 
University Press. 
Fitzmaurice, G.M., Laird, N.M. & Ware, J.H., 2004. Applied Longitudinal Analysis, 
Hoboken, New Jersey: John Wiley & Sons. 
Jang, M.J., 2011. Working correlation selection in generalized estimating equations. 
University of Iowa. Available at: http://ir.uiowa.edu/etd/2719 [Accessed April 9, 
2016]. 
Laird, N.M., Missing data in longitudinal studies. Statistics in medicine, 7(1-2), pp.305–
15. Available at: http://www.ncbi.nlm.nih.gov/pubmed/3353609 [Accessed May 9, 
2016]. 
Liang, K.-Y. & Zeger, S.L., 1986. Longitudinal Data Analysis Using Generalized 
Linear Models. Biometrika, 73(1), pp.13–22. Available at: 
http://links.jstor.org/sici?sici=0006-
3444%28198604%2973%3A1%3C13%3ALDAUGL%3E2.0.CO%3B2-D 
[Accessed April 9, 2016]. 
Meren, Ü.H. et al., 2015. The Effect of the Risk Related Personal Genetic Data on 
Adherence to and Effectiveness of Hypertension Treatment on Estonian Patients: 
an Overview of the Methodology of the Randomised Study. Eesti Arst, (94), 
pp.118–122. 
Morisky, D.E., Green, L.W. & Levine, D.M., 1986. Concurrent and predictive validity 
of a self-reported measure of medication adherence. Medical care, 24(1), pp.67–
74. Available at: http://www.ncbi.nlm.nih.gov/pubmed/3945130 [Accessed May 4, 
2016]. 
33 
 
Pan, W., 2001. Akaike’s Information Criterion in Generalized Estimating Equations. 
Biometrics, 57(1), pp.120–125. Available at: http://links.jstor.org/sici?sici=0006-
341X%28200103%2957%3A1%3C120%3AAICIGE%3E2.0.CO%3B2-Q 
[Accessed April 29, 2016]. 
Rubin, D.B., 1976. Inference and Missing Data. Biometrika, 63(3), pp.581–592. 
SAS Institute Inc., 2014. SAS/STAT® 13.2 User’s Guide, Cary, NC: SAS Institute Inc. 
Available at: 
http://support.sas.com/documentation/cdl/en/statug/67523/PDF/default/statug.pdf. 
SAS Institute Inc., 2011. SAS/STAT® 9.3 User’s Guide, Cary, NC: SAS Institute Inc. 
Available at: 
https://support.sas.com/documentation/cdl/en/statug/63962/PDF/default/statug.pdf. 
Svarstad, B.L. et al., 1999. The Brief Medication Questionnaire: a tool for screening 
patient adherence and barriers to adherence. Patient education and counseling, 
37(2), pp.113–24. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14528539 
[Accessed May 4, 2016]. 
Wang, Y.-G. & Carey, V., 2003. Working correlation structure misspecification, 
estimation and covariate design: Implications for generalised estimating equations 
performance. Biometrika, 90(1), pp.29–41. Available at: 
http://biomet.oupjournals.org/cgi/doi/10.1093/biomet/90.1.29 [Accessed May 9, 
2016]. 
Zeger, S.L. & Liang, K.-Y., 1986. Longitudinal Data Analysis for Discrete and 
Continuous Outcomes. Biometrics, 42(1), p.121. Available at: 
http://www.jstor.org/stable/2531248?origin=crossref [Accessed April 9, 2016]. 
  
34 
 
7. Appendix 
7.1 Correlation structures 
Figure 7.1-1 Examples of Independence, exchangeable, autoregressive(1), Toeplitz and 
unstructured correlation structures.  
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7.2 PROC GLIMMIX contrasted with PROC GENMOD  
The following is from SAS user guide (SAS Institute Inc. 2011). 
SAS procedures GENMOD and GLIMMIX can both fit GEE-type models. However, 
GENMOD does not allow to add random effects with GEE models (with REPEATED 
statement). 
The GEE estimation in GENMOD procedure uses only R-side covariances whereas 
GLIMMIX has R-side covariances and also G-side random effects. There is a difference 
in estimating the covariance parameters: GENMOD estimates these by the method of 
moments and GLIMMIX by likelihood-based methods.   
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7.3 IndiMed study design and timeline 
Figure 7.3-1 Study design, explanations are in text.  
47 data collectors 
Randomization 
Intervention group 24 data collectors 
Physicians in Tartu: 6 
Physicians in Tallinn: 12 
ITK cardiologists: 6 
 Control group 23 data collectors 
Physicians in Tartu: 6 
Physicians in Tallinn: 12 
ITK cardiologists: 5 
Involvement of patients: 
150 patients 
Involvement of patients: 
150 patients 
 
Visit 1: 
Inclusion criteria, informed consent, history, demographic and physical characteristics, 
RR, blood sample for DNA, prescription of treatment 
Visit 2 (1.5 months after visit 1): 
Physical characteristics, RR, evaluation 
of medication compliance, treatment 
correction if necessary, 
explaining DNA test results 
Visit 2 (1.5 months after visit 1): 
Physical characteristics, RR, evaluation 
of medication compliance, treatment 
correction if necessary 
 
Visit 3 (3.5 months after visit 1): 
Physical characteristics, RR, evaluation of medication compliance, treatment correction 
if necessary 
 
Visit 4 (6 months after visit 1): 
Physical characteristics, RR, evaluation 
of medication compliance, treatment 
correction if necessary 
Visit 4 (6 months after visit 1): 
Physical characteristics, RR, evaluation 
of medication compliance, treatment 
correction if necessary,  
explaining DNA test results 
 
Visit 5 (12 months after visit 1): 
Physical characteristics, RR, evaluation of medication compliance, treatment correction 
if necessary 
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7.4 Tables of descriptive statistics 
Table 7.4-1 Distribution of patients’ smoking by study group. 
Smoking N % 
Yes 93 38.75 
No 147 61.25 
Total 240 100.0 
 
Table 7.4-2 Subjects’ completed level of education by study group. 
Level of 
education 
Primary 
school 
Middle 
school  
High or 
vocational 
school 
Bachelor’s 
degree  
Scientific 
degree 
MSc/PhD 
Missing 
Group N (%) N (%) N (%) N (%) N (%) N (%) 
Intervention 2 (0.8) 17 (7.1) 72 (30.0) 29 (12.1) 5 (2.1) 2 (0.8) 
Control 0 (0.0) 19 (7.9) 62 (25.8) 26 (10.8) 5 (2.1) 1 (0.5) 
Total 2 (0.8) 36 (15.0) 134 (55.8) 55 (22.9) 10 (4.2) 3 (1.3) 
 
Table 7.4-3 Missing values for blood pressure by visit and study group. 
Visit Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 
Group 𝑵    
(%) 
𝑴𝒊𝒔∗ 
(%) 
𝑵  
(%) 
𝑴𝒊𝒔∗ 
(%) 
𝑵  
(%) 
𝑴𝒊𝒔∗ 
(%) 
𝑵  
(%) 
𝑴𝒊𝒔∗ 
(%) 
𝑵  
(%) 
𝑴𝒊𝒔∗ 
(%) 
Interve-
ntion 
127 
(52.9) 
0 
(0.0) 
125 
(52.1) 
2 
(0.8) 
114 
(47.5) 
13 
(5.4) 
106 
(44.1) 
21 
(8.8) 
79 
(32.9) 
48 
(20.0) 
Control 113 
(47.1) 
0 
(0.0) 
111 
(46.3) 
2 
(0.8) 
107 
(44.6) 
6 
(2.5) 
101 
(42.1) 
12 
(5.0) 
53 
(22.1) 
60 
(25.0) 
Total 240 
(100.0) 
0 
(0.0) 
236 
(98.4) 
4 
(1.6) 
221 
(92.1) 
19 
(7.9) 
207 
(86.2) 
33 
(13.8) 
132 
(55.0) 
108 
(45.0) 
 ∗ Mis: Missing 
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7.5 Distribution of systolic and diastolic blood pressures 
 
Figure 7.5-1 Distribution of log-transformed systolic blood pressure over all visits and 
subjects. 
 
Figure 7.5-2 Distribution of diastolic blood pressure over all visits and subjects. 
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Figure 7.5-3 Distribution of log-transformed diastolic blood pressure over all visits and 
subjects. 
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7.6 Tables of analysis results  
 
Model 1. 𝒍𝒐𝒈(𝒀)~𝒈𝒓𝒐𝒖𝒑 
 
Table 7.6-1 Analysis of GEE parameter estimates, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝. 
Response Parameter Estimate SE Z p-value 
Systolic Intercept 4.9562 0.0061 816.17 <.0001 
 Group (Intervention) -0.0136 0.0079 -1.72 0.0859 
 
Table 7.6-2 Score statistics for Type III GEE analysis, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝. 
Response Parameter DF ChiSq p-value 
Systolic Group 1 2.91 0.0878 
 
 
Table 7.6-3 Score statistics for Type III GEE analysis, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝. 
Response Parameter DF ChiSq p-value 
Diastolic Group 1 9.59 0.0020 
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Model 2. 𝒍𝒐𝒈(𝒀)~𝒈𝒓𝒐𝒖𝒑 + 𝒗𝒊𝒔𝒊𝒕 + 𝒅𝒐𝒄𝒕𝒐𝒓 
 
Table 7.6-4 Analysis of GEE parameter estimates, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟. Note that rows for doctor are omitted. 
Response Parameter Estimate SE Z p-value 
Systolic Intercept 5.0336 0.0183 274.71 <.0001 
 Group (Intervention) 0.0584 0.0106 5.29 <.0001 
 Visit (2) -0.1024 0.0066 -15.43 <.0001 
 Visit (3) -0.1228 0.0068 -17.97 <.0001 
 Visit (4) -0.1201 0.0070 -17.15 <.0001 
 
Table 7.6-5 Score statistics for Type III GEE analysis, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟. 
Response Parameter DF ChiSq p-value 
Systolic Group 1 3.65 0.0559 
 Visit 3 150.64 <.0001 
 Doctor 33 32.09 0.5121 
 
Table 7.6-6 Analysis of GEE parameter estimates, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟. Note that rows for doctor are omitted. 
Response Parameter Estimate SE Z p-value 
Diastolic Intercept 4.5724 0.0190 241.22 <.0001 
 Group (Intervention) -0.0397 0.0315 -1.26 0.2068 
 Visit (2) -0.0842 0.0062 -13.54 <.0001 
 Visit (3) -0.1006 0.0069 -14.52 <.0001 
 Visit (4) -0.1112 0.0071 -15.73 <.0001 
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Table 7.6-7 Score statistics for Type III GEE analysis, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟. 
Response Parameter DF ChiSq p-value 
Diastolic Group 1 1.22 0.2694 
 Visit 3 139.47 <.0001 
 Doctor 33 66.98 0.0004 
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Model 3. 𝐥𝐨𝐠 (𝒀)~𝒈𝒓𝒐𝒖𝒑 + 𝒗𝒊𝒔𝒊𝒕 + 𝒅𝒐𝒄𝒕𝒐𝒓 + 𝑩𝑴𝑰 + 𝒂𝒈𝒆 + 𝒔𝒎𝒐𝒌𝒊𝒏𝒈 +
𝒆𝒅𝒖𝒄𝒂𝒕𝒊𝒐𝒏 
 
Table 7.6-8 Analysis of GEE parameter estimates, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟 + 𝐵𝑀𝐼 + 𝑎𝑔𝑒 + 𝑠𝑚𝑜𝑘𝑖𝑛𝑔 + 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛. Note that 
rows for doctor are omitted.  
Response Parameter Estimate SE Z p-value 
Systolic Intercept 4.8569 0.0370 131.15 <.0001 
 Group (Intervention) 0.0129 0.0248 0.52 0.6020 
 Visit (2) -0.1018 0.0067 -15.30 <.0001 
 Visit (3) -0.1211 0.0068 -17.88 <.0001 
 Visit (4) -0.1196 0.0071 -16.83 <.0001 
 BMI 0.0035 0.0009 3.84 0.0001 
 Smoking (yes) 0.0101 0.0084 1.21 0.2269 
 Education (middle) 0.0163 0.0151 1.08 0.2801 
 Education (high) -0.0028 0.0096 -0.29 0.7724 
 Education (BSc) -0.0116 0.0128 -0.90 0.3675 
 Education (MSc/PhD) -0.0524 0.0205 -2.56 0.0106 
 Age 0.0008 0.0004 1.96 0.0495 
 
Table 7.6-9 Score statistics for Type III GEE analysis, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟 + 𝐵𝑀𝐼 + 𝑎𝑔𝑒 + 𝑠𝑚𝑜𝑘𝑖𝑛𝑔 + 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛. 
Response Parameter DF ChiSq p-value 
Systolic Group 1 0.23 0.6304 
 Visit 3 147.53 <.0001 
 BMI 1 12.59 0.0004 
 Smoking 1 1.45 0.2291 
 Doctor 33 26.33 0.7881 
 Education 4 7.80 0.0991 
 Age 1 3.78 0.0517 
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Table 7.6-10 Analysis of GEE parameter estimates, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟 + 𝐵𝑀𝐼 + 𝑎𝑔𝑒 + 𝑠𝑚𝑜𝑘𝑖𝑛𝑔 + 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛. Note that 
rows for doctor are omitted. 
Response Parameter Estimate SE Z p-value 
Diastolic Intercept 4.4737 0.0526 84.98 <.0001 
 Group (Intervention) -0.0608 0.0435 -1.40 0.1625 
 Visit (2) -0.0845 0.0063 -13.45 <.0001 
 Visit (3) -0.1004 0.0070 -14.27 <.0001 
 Visit (4) -0.1109 0.0072 -15.46 <.0001 
 BMI 0.0032 0.0011 2.86 0.0042 
 Smoking (yes) 0.0196 0.0084 2.33 0.0196 
 Education (middle) -0.0299 0.0333 -0.90 0.3696 
 Education (high) -0.0234 0.0320 -0.73 0.4641 
 Education (BSc) -0.0309 0.0327 -0.94 0.3457 
 Education (MSc/PhD) -0.0313 0.0374 -0.84 0.4031 
 Age 0.0008 0.0004 2.34 0.0194 
 
Table 7.6-11 Score statistics for Type III GEE analysis, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑔𝑟𝑜𝑢𝑝 + 𝑣𝑖𝑠𝑖𝑡 + 𝑑𝑜𝑐𝑡𝑜𝑟 + 𝐵𝑀𝐼 + 𝑎𝑔𝑒 + 𝑠𝑚𝑜𝑘𝑖𝑛𝑔 + 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛. 
Response Parameter DF ChiSq p-value 
Diastolic Group 1 1.61 0.2045 
 Visit 3 136.02 <.0001 
 Doctor 33 55.61 0.0082 
 BMI 1 7.15 0.0075 
 Smoking 1 5.24 0.0220 
 Education 4 1.45 0.8355 
 Age 1 5.14 0.0234 
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Table 7.6-12 Systolic blood pressure model with doctor as a random effect. Solution for 
fixed effects. 
Response Effect Estimate SE DF t p-value 
Systolic Intercept 4.8754 0.0271 228 180.06 <.0001 
 Group (Intervention) -0.0100 0.0073 648 -1.37 0.1712 
 Visit (2) -0.1020 0.0066 648 -15.35 <.0001 
 Visit (3) -0.1214 0.0068 648 -17.95 <.0001 
 Visit (4) -0.1196 0.0071 648 -16.86 <.0001 
 BMI 0.0038 0.0008 648 4.83 <.0001 
 Age 0.0008 0.0004 648 2.28 0.0227 
 Education (middle) 0.0263 0.0124 648 2.12 0.0345 
 Education (high) 0.0064 0.0066 648 0.96 0.3360 
 Education (BSc) 0.0001 0.0089 648 0.01 0.9908 
 Education (MSc/PhD) -0.0288 0.0169 648 -1.70 0.0897 
 Smoking (yes) 0.0143 0.0078 648 1.84 0.0670 
 
 
Table 7.6-13 Systolic blood pressure model with doctor as a random effect. Type III 
tests of fixed effects. 
Response Parameter DF F p-value 
Systolic Group 1 1.88 0.1712 
 Visit 3 135.01 <.0001 
 BMI 1 23.38 <.0001 
 Age 1 5.22 0.0227 
 Education 4 2.28 0.0595 
 Smoking 1 3.37 0.0670 
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Table 7.6-14 Diastolic blood pressure model with doctor as a random effect. Solution 
for fixed effects. 
Response Effect Estimate SE DF t p-value 
Diastolic Intercept 4.3889 0.0439 228 99.85 <.0001 
 Group (Intervention) -0.0264 0.0087 648 -3.05 0.0024 
 Visit (2) -0.0848 0.0063 648 -13.45 <.0001 
 Visit (3) -0.1008 0.0070 648 -14.31 <.0001 
 Visit (4) -0.1107 0.0072 648 -15.39 <.0001 
 BMI 0.0044 0.0010 648 4.40 <.0001 
 Age 0.0011 0.0004 648 3.05 0.0024 
 Education (middle) -0.0340 0.0313 648 -1.08 0.2784 
 Education (high) -0.0113 0.0293 648 -0.39 0.7003 
 Education (BSc) -0.0168 0.0303 648 -0.56 0.5781 
 Education (MSc/PhD) 0.0087 0.0339 648 0.26 0.7967 
 Smoking (yes) 0.0215 0.0091 648 2.38 0.0177 
 
Table 7.6-15 Diastolic blood pressure model with doctor as a random effect. Type III 
tests of fixed effects. 
Response Effect DF F p-value 
Diastolic Group 1 9.28 0.0024 
 Visit 3 107.23 <.0001 
 BMI 1 19.35 <.0001 
 Age 1 9.31 0.0024 
 Education 4 1.21 0.3060 
 Smoking 1 5.66 0.0177 
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Model 4. 𝒍𝒐𝒈(𝒀)~𝒔𝒖𝒃𝒈𝒓𝒐𝒖𝒑 
 
Table 7.6-16 Score statistics for Type III GEE analysis, systolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑠𝑢𝑏𝑔𝑟𝑜𝑢𝑝. 
Response Parameter DF ChiSq p-value 
Systolic Subgroup 2 9.69 0.0079 
 
 
Table 7.6-17 Score statistics for Type III GEE analysis, diastolic blood pressure, model 
𝑙𝑜𝑔(𝑌)~𝑠𝑢𝑏𝑔𝑟𝑜𝑢𝑝. 
Response Parameter DF ChiSq p-value 
Diastolic Subgroup 2 13.80 0.0010 
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